The myth of the magic pill

Family Therapy as an Alternative to Medication: An Appraisal of Pharmland

Volumn , Issue , 2004, Pages 171-192

  Duncan, Barry ^a   Miller, Scott ^a   Sparks, Jacqueline ^a,b  

^a Institute for the Study of Therapeutic Change   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24344446462     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203483770-21     Document Type: Chapter

References (23)

1. American Association of Marriage and Family Therapy. (1998). Intimacy and depression: the silent epidemic [Brochure]. Washington, D.C.: AAMFT.
2. Blatt, S.J., Zuroff, D.C., Quinlan, D.M., and Pilkonis, P. (1996). Interpersonal factors in brief treatment of depression: Further analyses of the NIMH treatment of depression collaborative research program. Journal of Consulting and Clinical Psychology, 64, 162-171.
3. Breggin, P. (1999). Your drug may be your problem. Reading, MA: Perseus Books.
4. Day, K. (1995, January 18). Depression awareness-or a Prozac pitch? The Washington Post, C6.
5. Elkin, I., Shea, T., Watkins, J.T., Imber, S.D., Sotsky, S.M., Collins, J. R, Glass, D. R., Pilkonis, P.A., Leber, W.R., Docherty, J. P, Fiester, S.J., & Parloff, M.B. (1989). National institute of mental health treatment of depression collaborative research program: General effectiveness of treatments. Archives of General Psychiatry, 46, 971-982.
6. Emslie, G. I, Rush, A.J., Weinberg, W.A., Kowatch, R.A., Hughes, C.W., Carmody, T., Rintelmann, J. (1997). A double-blind, randomized, placebocontrolled trial of fluoxetien in children and adolescents with depression. Archives of General Psychiatry, 54(1), 1031-1037.
7. Fisher, S., & Greenberg, R.R. (Eds). (1997b). From Placebo to panacea: Putting psychiatric drugs to the test. New York: Wiley.
8. Friedberg, M., Saffran, B., Stinson, T., Nelson, W., & Bennet, M. (1999). Evaluation of conflict of interest in economic analyses of new drugs used in oncology. Journal of the American Medical Association, 282, 1453-1457.
9. Greenberg, R. P, Bornstein, R. F, Greenberg, M.D., & Fisher, S. (1992). A metaanalysis of antidepressant outcome under “blinder�? conditions. Journal of Consulting and Clinical Psychology, 60, 664-669.
10. Greenberg, R., Bornstein, R., Zborowski, M., Fisher, S., & Greenberg, M. (1994). A meta-analysis of fluoxetine outcome in the treatment of depression. Journal of Nervous and Mental Disease, 182, 547-551.
11. Gurin, R. (1992, February). Pushing drugs to doctors. Consumer Reports, 87-94.
12. Huffington, A. (1999, June 10). The dangers of the White House mental health conference. Arianna Online. (www.ariannaonline.com)
13. Johnson, J., & Bootman (1995). Drug-related morbidity and mortality. Archives of Internal Medicine, 155, 1949-1956.
14. Kirsch, L, & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A metaanalysis of antidepressant medication. Prevention & Treatment, Article 0002a. Available at http://journals.apa.org/prevention/volumel/pre0010002ahtml.
15. Krupnick, J.L., Sotsky, S.M., Simmens, S., Moyher, J., Elkin, I., Watkins, J., & Pilkonis, P.A. (1996). The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Project.�? Journal of Consult-ing and Clinical Psychology, 64, 532-539.
16. Lambert, M, Hatch, D., Kingston, M, & Edwards, B. (1986). Zung, Beck, and Hamilton rating scales as measures of treatment outcome: A met-analytic comparison. Journal of Consulting and Clinical Psychology, 54, 54-59.
17. Monmaney, T. (1999, October 21). Medical journal may have flouted own ethics eight times. The Los Angeles Times, 1.
18. Mosher, L. (1999, September). I want no part of it anymore. Psychology Today, 40-41, 80.
19. Seligman, M.E. P. (1995). The effectiveness of psychotherapy: The Consumer Reports Survey,�? American Psychologist, 50, 965-974.
20. Shea, M., Elkin, I., Imber, S., Sotsky, S., Watkins, J., Collins, J., Pilkonis, P, Beckham, R., Glass, D., Dolan, C., & Parloff, M. (1992). Course of depressive symptoms over follow up: The NIMH TDCRP. Archives of General Psychiatry, 49(10), 782-87.
21. Tanouye, E. (1998, January 8). Does corporate funding influence research? The Wall Street Journal, B1, B6.
22. Tracy, A. (1994). Prozac: Panacea or Pandora? West Jordan, UT: Cassica Publications.
23. Valenstein, E. (1998). Blaming the Brain. New York: Free Press.